We are live on
!
Find out more
FAM
Fred Alger Management Portfolio holdings
AUM
$22.8B
1-Year Est. Return
64.63%
This Fund
S&P 500
This Quarter
Est. Return
-0.24%
1 Year Est. Return
+64.63%
3 Year Est. Return
+243.99%
5 Year Est. Return
+318.3%
10 Year Est. Return
+1,899.64%
AUM
$25.5B
AUM Growth
-$551M
(-2.1%)
Cap. Flow
+$119M
Cap. Flow
% of AUM
0.47%
Top 10 Holdings %
Top 10 Hldgs %
35.92%
Holding
572
New
64
Increased
174
Reduced
183
Closed
94
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$372M |
| 2 |
Fidelity National Information Services
FIS
|
+$228M |
| 3 |
NXP Semiconductors
NXPI
|
+$200M |
| 4 |
XLNX
Xilinx Inc
XLNX
|
+$150M |
| 5 |
Apple
AAPL
|
+$149M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$212M |
| 2 |
Broadcom
AVGO
|
+$193M |
| 3 |
Qualcomm
QCOM
|
+$184M |
| 4 |
AABA
Altaba Inc
AABA
|
+$173M |
| 5 |
WP
Worldpay, Inc.
WP
|
+$143M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.17% |
| 2 | Healthcare | 21.04% |
| 3 | Consumer Discretionary | 15.25% |
| 4 | Communication Services | 9.61% |
| 5 | Financials | 9.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
351
Endava
DAVA
$153M
| $767K | ﹤0.01% |
20,254
-69,161
| -77% | -$2.65M |
|
|
BHVN
352
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $751K | ﹤0.01% |
18,000
-2,000
| -10% | -$84.5K |
|
|
APLS
353
DELISTED
Apellis Pharmaceuticals
APLS
| $747K | ﹤0.01% |
31,000
+28,000
| +933% | +$771K |
|
354
Protolabs
PRLB
$1.78B
| $746K | ﹤0.01% |
+7,309
| New | +$745K |
|
355
Afya
AFYA
$1.32B
| $737K | ﹤0.01% |
+28,753
| New | +$742K |
|
356
Fulcrum Therapeutics
FULC
$248M
| $711K | ﹤0.01% |
+107,138
| New | +$1.19M |
|
357
Twilio
TWLO
$29.5B
| $706K | ﹤0.01% |
6,421
-14,154
| -69% | -$1.84M |
|
358
Tetra Tech
TTEK
$8.7B
| $697K | ﹤0.01% |
40,175
| – | – |
|
359
Okta
OKTA
$23.7B
| $690K | ﹤0.01% |
7,008
-17,613
| -72% | -$2.2M |
|
360
Ascendis Pharma A/S
ASND
$16.7B
| $674K | ﹤0.01% |
7,000
| – | – |
|
361
Valero Energy
VLO
$88.7B
| $653K | ﹤0.01% |
7,655
| – | – |
|
362
Fate Therapeutics
FATE
$270M
| $621K | ﹤0.01% |
40,000
+30,000
| +300% | +$575K |
|
363
DuPont de Nemours
DD
$19B
| $599K | ﹤0.01% |
6,694
-174
| -3% | -$15.3K |
|
364
Freshpet
FRPT
$3.01B
| $597K | ﹤0.01% |
12,000
| – | – |
|
365
Allegion
ALLE
$13.7B
| $580K | ﹤0.01% |
5,600
| – | – |
|
366
GeoPark
GPRK
$601M
| $579K | ﹤0.01% |
31,565
-11,394
| -27% | -$204K |
|
|
ARQL
367
DELISTED
Arqule Inc
ARQL
| $574K | ﹤0.01% |
80,000
| – | – |
|
|
IMMU
368
DELISTED
Immunomedics Inc
IMMU
| $570K | ﹤0.01% |
+43,000
| New | +$632K |
|
369
Penumbra
PEN
$12.6B
| $538K | ﹤0.01% |
+4,000
| New | +$619K |
|
370
American Express
AXP
$227B
| $520K | ﹤0.01% |
4,400
-600
| -12% | -$73.6K |
|
371
Woodward
WWD
$24.5B
| $519K | ﹤0.01% |
4,812
| – | – |
|
372
Gossamer Bio
GOSS
$100M
| $504K | ﹤0.01% |
30,000
-20,000
| -40% | -$398K |
|
373
MeiraGTx Holdings
MGTX
$1.09B
| $494K | ﹤0.01% |
31,000
+13,000
| +72% | +$303K |
|
374
BioMarin Pharmaceuticals
BMRN
$12B
| $455K | ﹤0.01% |
6,756
-13,247
| -66% | -$1.02M |
|
375
NMI Holdings
NMIH
$3.34B
| $402K | ﹤0.01% |
+15,300
| New | +$418K |
|
Similar funds
CAM
BA
AM
SAM
CHP
Fred Alger Management's Q3 2019 Portfolio in Review
As of Q3 2019, Fred Alger Management held 572 positions worth $25.5B, down 2.1% from $26B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
Fred Alger Management's Q3 2019 filing shows 64 new, 174 increased, 183 reduced and 94 closed positions. Its largest new stake was Alteryx Inc: 727,681 shares worth $78.2M. The largest sale was UnitedHealth, an estimated $212M.
By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 29% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Fred Alger Management's largest Q3 2019 buy was Alteryx Inc: 727,681 shares worth $78.2M.
- Fred Alger Management added most to Alibaba in Q3 2019, an estimated $372M increase.
- Fred Alger Management's biggest Q3 2019 reduction was UnitedHealth, cutting an estimated $212M.
- Fred Alger Management fully exited Worldpay, Inc. in Q3 2019, selling an estimated $143M.
- Fred Alger Management's ten largest holdings make up 36% of its $25.5B portfolio in Q3 2019.
- Fred Alger Management opened 64 new positions and closed 94 in Q3 2019.
- Fred Alger Management's portfolio value fell 2.1% quarter-over-quarter to $25.5B.
Based on Fred Alger Management's 13F filing for Q3 2019, filed 14 Nov 2019.